2017
DOI: 10.1016/j.psyneuen.2016.10.025
|View full text |Cite
|
Sign up to set email alerts
|

Selective corticotropin-releasing factor 1 receptor antagonist E2508 reduces restraint stress-induced defecation and visceral pain in rat models

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(13 citation statements)
references
References 42 publications
0
13
0
Order By: Relevance
“…Further supporting evidence for a role of amygdala CRH in stress-induced visceral sensitivity demonstrated that intra-CeA CRH administration increased colonic sensitivity via CRH 1 receptor activation in stress-naïve male rats (Su et al, 2015 ). Peripheral administration of a CRH 1 antagonists dose-dependently reduced stress-induced colonic sensitivity and decreased stress-induced fecal pellet output (Million et al, 2013 ; Taguchi et al, 2017 ). Similarly, a peripherally restricted CRH 1 agonist induced colonic hypersensitivity in stress-naïve adult male rats while a CRH 2 antagonist was also able to inhibit stress-induced colonic hypersensitivity (Larauche et al, 2009 ; Nozu et al, 2014 ; Mulak et al, 2015 ).…”
Section: Neurotransmitters In Stress Pathways That Modulate Visceral mentioning
confidence: 99%
“…Further supporting evidence for a role of amygdala CRH in stress-induced visceral sensitivity demonstrated that intra-CeA CRH administration increased colonic sensitivity via CRH 1 receptor activation in stress-naïve male rats (Su et al, 2015 ). Peripheral administration of a CRH 1 antagonists dose-dependently reduced stress-induced colonic sensitivity and decreased stress-induced fecal pellet output (Million et al, 2013 ; Taguchi et al, 2017 ). Similarly, a peripherally restricted CRH 1 agonist induced colonic hypersensitivity in stress-naïve adult male rats while a CRH 2 antagonist was also able to inhibit stress-induced colonic hypersensitivity (Larauche et al, 2009 ; Nozu et al, 2014 ; Mulak et al, 2015 ).…”
Section: Neurotransmitters In Stress Pathways That Modulate Visceral mentioning
confidence: 99%
“…Even though a number of IBS-related factors have been identified in animal and patients studies ( 1 , 12 , 13 , 24 , 25 ), a full landscape of IBS-associated genes at the molecular level is needed to get a comprehensive understanding of IBS pathogenesis. A previous small bowel mucosal gene expression study has reported that both transcriptome expression and immune-related mechanisms are altered in IBS-D patients ( 27 ).…”
Section: Introductionmentioning
confidence: 99%
“…Among the pharmacotherapeutic approaches targeting the mechanisms involved in sensitization are: tricyclic antidepressants (TCAs) such as nortriptyline or amitriptyline, NMDA receptor antagonists, such as ketamine, that target temporal summation and secondary (mechanical) hyperalgesia, and selective balanced serotonin and noradrenaline-reuptake inhibitors (SNRIs), such as duloxetine, which influence descending modulation and potentially opioids, gabapentoids, or calcium channel alpha(2)delta ligands (Nijs et al, 2011;(p.196) Woolf, 2011). Novel pharmacological developments include the potential for CRF modulators in the treatment of prolonged pain syndromes associated with HPA-axis irregularities (Lariviere & Melzack, 2000;Taguchi et al, 2017). Although drugs have shown to have modest beneficial effects in the treatment of chronic pain syndromes, it should be noted that since drugs act centrally, they can also elicit serious side effects.…”
Section: Pharmacotherapeutic Approachesmentioning
confidence: 99%